1-[1-[(1R,2R)-2-aminocyclohexanecarbonyl]piperidin-4-yl]-3-[3-methyl-5-(trifluoromethyl)phenyl]propan-2-one
C23H31F3N2O2 — CID 158023619
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[1-[(1R,2R)-2-aminocyclohexanecarbonyl]piperidin-4-yl]-3-[3-methyl-5-(trifluoromethyl)phenyl]propan-2-one
1-[1-[(1R,2R)-2-aminocyclohexanecarbonyl]piperidin-4-yl]-3-[3-methyl-5-(trifluoromethyl)phenyl]propan-2-one (PubChem CID 158023619) has the molecular formula C23H31F3N2O2 and a molecular weight of 424.51 g/mol. Its IUPAC name is 1-[1-[(1R,2R)-2-aminocyclohexanecarbonyl]piperidin-4-yl]-3-[3-methyl-5-(trifluoromethyl)phenyl]propan-2-one.
Molecular Properties
| Compound Name | 1-[1-[(1R,2R)-2-aminocyclohexanecarbonyl]piperidin-4-yl]-3-[3-methyl-5-(trifluoromethyl)phenyl]propan-2-one |
|---|---|
| PubChem CID | 158023619 |
| Molecular Formula | C23H31F3N2O2 |
| Molecular Weight | 424.51 g/mol |
| Exact Mass | 424.23 |
| IUPAC Name | 1-[1-[(1R,2R)-2-aminocyclohexanecarbonyl]piperidin-4-yl]-3-[3-methyl-5-(trifluoromethyl)phenyl]propan-2-one |
| SMILES | Cc1cc(CC(=O)CC2CCN(C(=O)[C@@H]3CCCC[C@H]3N)CC2)cc(C(F)(F)F)c1 |
| InChI | InChI=1S/C23H31F3N2O2/c1-15-10-17(12-18(11-15)23(24,25)26)14-19(29)13-16-6-8-28(9-7-16)22(30)20-4-2-3-5-21(20)27/h10-12,16,20-21H,2-9,13-14,27H2,1H3/t20-,21-/m1/s1 |
| InChIKey | ATQITIDZBQVAOS-NHCUHLMSSA-N |
| XLogP | 4.27 |
| TPSA | 63.40 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.51 |
| LogP ≤ 5 | 4.27 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158023619 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.